Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05652283
What this trial is testing

Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Who this might be right for
Ovarian Cancer
Bai-Rong Xia 37
Testing effectiveness (Phase 2)Study completedNCT00004083
What this trial is testing

Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
NYU Langone Health
Not applicableStudy completedNCT03324945
What this trial is testing

Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients

Who this might be right for
Chemotherapy-induced Cognitive Impairment
Rachel Miller 14
Not applicableStudy completedNCT02578888
What this trial is testing

Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies

Who this might be right for
Cervical CarcinomaOvarian CarcinomaPrimary Peritoneal Carcinoma+7 more
Albert Einstein College of Medicine 95
Large-scale testing (Phase 3)Study completedNCT00006454
What this trial is testing

Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian Cancer
AGO Study Group
Not applicableUnknownNCT05840029
What this trial is testing

VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES

Who this might be right for
Ovarian Cancer
Alexandria University 68
Not applicableUnknownNCT01268956
What this trial is testing

Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis

Who this might be right for
Ovarian Cancer
Hospital Universitari de Bellvitge 60
Testing effectiveness (Phase 2)Looking for participantsNCT06710756
What this trial is testing

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastric CancerEsophageal Cancer+5 more
Perspective Therapeutics 112
Testing effectiveness (Phase 2)Looking for participantsNCT06580002
What this trial is testing

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric Cancer+19 more
University of California, Irvine 75
Not applicableNot Yet RecruitingNCT07503054
What this trial is testing

Ovarian Cancer Screening and AI

Who this might be right for
Ovarian Cancer Screening Recommendations by Gynecologists
Charite University, Berlin, Germany 350
Not applicableStudy completedNCT04360629
What this trial is testing

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Who this might be right for
Advanced Ovarian Cancer
Jun Zhang 151
Not applicableUnknownNCT05290961
What this trial is testing

The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening

Who this might be right for
Ovarian Neoplasms
Chongqing University Cancer Hospital 30
Early research (Phase 1)Study completedNCT02575651
What this trial is testing

A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Jiangsu HengRui Medicine Co., Ltd. 79
Early research (Phase 1)Study completedNCT02144051
What this trial is testing

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

Who this might be right for
Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor
AstraZeneca 32
Testing effectiveness (Phase 2)Study completedNCT03267589
What this trial is testing

Trial in Patients With Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 25
Not applicableActive Not RecruitingNCT02043158
What this trial is testing

Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 240
Early research (Phase 1)Study completedNCT00164658
What this trial is testing

Evaluating Tools for Health Promotion and Disease Prevention

Who this might be right for
Coronary Heart DiseaseStrokeDiabetes+3 more
Centers for Disease Control and Prevention 8,400
Post-approval studies (Phase 4)UnknownNCT03475589
What this trial is testing

Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations

Who this might be right for
Stage IV Cancer
Sun Yat-sen University 217
Testing effectiveness (Phase 2)Study completedNCT01001910
What this trial is testing

Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Albert Einstein College of Medicine 22
Not applicableStudy completedNCT02825420
What this trial is testing

Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients

Who this might be right for
Relapsed Ovarian Cancer
PharmaMar 220
Next Page